PD-L1 expression, EGFR mutations (EGFRm) and KRAS mutations (KRASm) in stage III unresectable non-small cell lung cancer (NSCLC) patientsDeirdre Cronin-Fenton,Tapashi Dalvi,Elizabeth Hedgeman,Mette Norgaard,Lars Pedersen,Hanh Hansen,Jon Fryzek,Jill Walker,Anders Mellemgaard,Torben R. Rasmussen,Norah Shire,James Rigas,Danielle Potter,Stephen Hamilton-Dutoit,Henrik T. SorensenPHARMACOEPIDEMIOLOGY AND DRUG SAFETY（2018）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
